范科米辛亚治疗度对黄金葡萄球菌的作用 隔离于血液透析患者的黄金葡萄球菌 血液透析患者的血清度低
Rodrigo Altoé Chagas1, Cristiana de Souza Silva1, Jéssica de Cássia Teixeira Birro1
1Department of Pathology, Health Sciences Center, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil.
Current microbiology
|January 17, 2024
概括
在血液透析患者中,亚治疗性万科米辛度降低了黄金葡萄球菌对抗生素的敏感性,并增加了其对血液的存活率.
科学领域:
- 传染性疾病 传染性疾病
- 腎臟病學 (nephrology) 是一種醫學專業.
- 微生物学 微生物学
背景情况:
- 与导管相关的感染是血液透析 (HD) 患者的重大风险,通常与产生生物膜的细菌有关.
- 甲基西林耐药黄金葡萄球菌 (MRSA) 细菌病在疾病发病患者中需要万科米辛治疗.
- 在HD患者中,亚治疗性万科米辛水平是常见的,可能会影响治疗疗效和耐药性.
研究的目的:
- 为了研究亚治疗度的万科米辛对黄金葡萄球菌的影响.
- 评估对细菌生长,抗微生物敏感性,对全血耐药性和生物膜形成的影响.
主要方法:
- 使用了17种来自HD患者细菌病的S. aureus菌株和2种参考菌株.
- 菌株在5天内暴露于万科米辛梯度 (0-10微克/毫升),以模拟HD剂量间隔.
- 评估了对生长曲线,抗菌素敏感性,全血杀菌活性和生物膜产生的影响.
主要成果:
- 没有观察到对金黄色葡萄球菌生长曲线的显著影响.
- 暴露导致了对万科米辛和托米辛的敏感性降低.
- 增加了S. aureus对抗全血的杀菌作用的存活率和菌株依赖生物膜的产生.
结论:
- 治疗后的万科米辛度可以降低黄金葡萄球菌对万科米辛和托米辛的敏感性.
- 这些度增强了黄金葡萄球菌的生存率,对抗全血杀菌效应.
- 这些发现突出了在血液透析患者中低于最佳范科米辛剂量的临床影响.
更多相关视频
相关概念视频
Renal Failure: Dose Adjustments
92
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
92
Dialysis
691
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
691
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Factors Affecting Renal Clearance: Renal Impairment
95
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
Time Course of Drug Effect
2.1K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.1K


